INSIGHTS ON PHARMACEUTICAL INSPECTION
-
Part I: Defining The Dye Ingress Operating Window
Dye ingress testing depends on pressure dynamics that shift with viscosity. Discover how these constraints narrow its operating window and call into question its reliability for high‑risk applications.
-
Test Kit Management: The Hidden Weak Point In Your Visual Inspection Program
A proper test kit management program is no longer a “nice-to-have”—it’s a compliance necessity. Without a structured system, you risk inspector drift, failed audits, and errors in batch release.
-
Innovation And Efficiency - Visual Inspection In The 21st Century
Digitizing your visual inspection processes is key to unlocking efficiency and ensuring compliance with global regulatory standards. Learn how to transition from paper-based systems to a digital database.
-
Risk Management Across The Pharmaceutical Product Lifecycle
Managing risk throughout the pharmaceutical lifecycle requires proactive strategies. Explore advanced detection methods and rigorous sampling that ensure product integrity.
-
Part II: Defining The Dye Ingress Operating Window2/12/2026
Learn about the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.
-
Advancing Drug Product Quality Through AVI And Future-Ready Infrastructure9/5/2025
Automated visual inspection (AVI) combines robotics, precision imaging, and sophisticated defect-recognition software to provide a scalable solution for expanding pipelines and rises in production volumes.
-
Visual Inspection Of Advanced Therapy Medicinal Products9/2/2025
Discover how expert database systems for inspection defect management and control help cell and gene therapies meet the requirements of USP-790 to assure they are essentially free from particulate matter.
-
OEE And Product Inspection2/13/2025
Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.
-
Visual Inspection Equipment To Deliver The Highest Product Integrity4/1/2025
Gain insight into an advanced inspection solution for pharmaceuticals that ensures drug integrity and reduces costs with flexible technologies, from lab development to high-volume production.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
The pharmaceutical industry continues to lead industries in terms of quality requirements and the value of data. The shift to more automated processes is less about the cost of human capital, but more about the pursuit of quality. The European Medicines Agency (EMA) updated Annex 1, driving for 100% inspection on fused containers and appropriate quality test measures for applications based on level of risk. The United States Pharmacopeia (USP) revamped Chapter 1207 on container closure integrity (CCI) to be prescriptive of deterministic technologies and encourages a deeper understanding of a container’s CCI requirements. The FDA continues to drive a ‘quality culture’ agenda versus a ‘compliance culture’, and the FDA has been explicitly targeting data integrity as a campaign for assuring quality. Every regulatory and guidance body is driving towards more reliable and accurate test methods.
-
Advanced inspection systems ensure packaging integrity, preventing contamination. Gain insight into automated solutions that improve quality, reduce waste, and integrate easily into production lines.
-
Learn how these non-destructive inspection technologies verify container closure system integrity with deterministic quantitative test methods for vials, ampoules, syringes, cartridges and auto-injectors.
-
Bottles come in a wide array of sizes and configurations, reflective of their diverse use in the health sciences industry. Typically, they exhibit a screw top closure threaded onto the bottle mouth, though sealing properties ranges from elastomeric liners, to o-rings, to induction seals and reliance on plastic-to-plastic contact and compression. One specific trend is the increase in need to test sterile bulk containers or sterile API containers. As the industry continues to move toward outsourcing or even insourcing through a network of suppliers or sites, transport of sterile drug product or API is becoming increasingly common. These types of containers are traditionally challenging to test, but can be qualified prior to use or as a proof of concept using helium leak detection.
-
Helium leak detection (HeLD) is routinely used and widely accepted for applications that require the utmost leak sensitivity.